Manzo Alessandro

TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer / V. Cirello, C. Colombo, D. Tosi, A. Manzo, M.O. Borghi, U. Gianelli, G. Gazzano, S. Ferrero, G. Dionigi, L. Persani, L. Fugazzola. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - (2025), pp. dgaf056.1-dgaf056.13. [Epub ahead of print] [10.1210/clinem/dgaf056]

TARGETING THE DNA DAMAGE RESPONSE PATHWAY FOR THE TREATMENT OF AGGRESSIVE THYROID CANCERS, IN VITRO STUDIES / A. Manzo ; tutor: L. Persani ; supervisore: V. Cirello ; coordinatore: N. Landsberger ; revisore esterno: E. Puxeddu, C. Nucera. Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, 2024 May 20. 36. ciclo, Anno Accademico 2022/2023.

Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants / V. Cirello, M. Lugaresi, C. Moneta, P. Dufour, A. Manzo, E. Carbone, C. Colombo, L. Fugazzola, C. Charlier, C. Pirard. - 13:3(2024), pp. e230192.1-e230192.15. [10.1530/etj-23-0192]

Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies / A. Manzo, V. Cirello, E.S. Grassi, C. Colombo, L. Fugazzola, L. Persani. ((Intervento presentato al 7. convegno BioMeTra Workshop tenutosi a Milano nel 2023.

Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer / V. Cirello, C. Colombo, A. Manzo, D. Tosi, U. Gianelli, G. Gazzano, S. Ferrero, L. Persani, L. Fugazzola. ((Intervento presentato al 45. convegno Annual Meeting of the European Thyroid Association : 9–12 September tenutosi a Milano nel 2023.